PKN2 and prostate carcinoma: Hence, focusing on the setting of prostate cancer, the aim of this study was to explore whether TPα and/or TPβ might also complex with and regulate the activity, neoplastic (proliferative and migratory) responses and, potentially, histone H3 Thr11 phosphorylation through PRK2 and PRK3.